Regulation & governance

Pharmacists are becoming the front door for cardiometabolic care. Policy is still treating them like the back office

Dementia prevention has a cardiometabolic blind spot

The Money Is Moving Into Cancer Screening. The Evidence Still Has to Catch Up.

Duchenne’s Accelerated Approval Faces Its Test

The Screwworm Border Did Not Hold. Now Mexico and the U.S. Are Betting on Flies.

New nicotine products could become the next major cardiovascular policy failure

Childhood obesity is the next cardiometabolic crisis already unfolding

Europe Opens Another Lung Cancer Door to China-Origin Immunotherapy

BMI is not enough. Cardiometabolic risk is hiding in where fat lives
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
